Table 6 The difference between Study and control groups concerning CKD stage and volume of contrast administrated for all patients
Variable | Study group | Control group | 95% confidence interval | P value | |
|---|---|---|---|---|---|
Lower | Upper | ||||
Contrast volume, ml | 185.83 ± 41.6 | 190.17 ± 42.6 | -10.8 | 19.6 | t = 0.57 p = 0.128 |
Mehran score | 5.7 ± 2.7 | 5.52 ± 2.5 | -1.12 | 0.76 | t= -0.38 p = 0.582 |
Predicted CI-AKI risk (%) | 12.4 ± 6.94 | 10.87 ± 4.23 | -3.6 | 0.54 | t= -1.45 p = 0.139 |
CI-AKI Development, No. (%) | 7 (11.7%) | 15 (25%) | 0.13 | 0.4 | X2 = 4.2 p = 0.048 |